Furthermore, in separate analyses in Caucasians and African American patients, FGF23 coherently emerged as the sole significant CKD-MBD biomarker that predicts death and CV events in the HDs population [142]. The gene discussed is FGF23; the disease is Marchiafava-Bignami disease.